✦ LIBER ✦

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease

✍ Scribed by Lonneke M.L. de Lau; Bruno H.C. Stricker; Monique M.B. Breteler

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 35 KB
Volume: 22
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.21582

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum uric acid levels and the risk of P

Serum uric acid levels and the risk of Parkinson disease

✍ Lonneke M. L. de Lau; Peter J. Koudstaal; Albert Hofman; Monique M. B. Breteler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Nonsteroidal anti-inflammatory drugs and

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

✍ Thanh G. Ton; Susan R. Heckbert; W.T. Longstreth Jr.; Mary Anne Rossing; Walter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

## Abstract Inflammation and oxidative stress have been implicated as pathogenic mechanisms in Parkinson's disease (PD). Evidence from in vitro and animal studies suggests a possible protective role of nonsteroidal anti‐inflammatory drugs (NSAIDs), including aspirin. We investigated the risk of PD

Calcium channel blocker use and risk of

Calcium channel blocker use and risk of Parkinson's disease

✍ Kelly Claire Simon; Xiang Gao; Honglei Chen; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract We investigated whether the use of calcium channel blockers (CCBs) was associated with a reduced risk of Parkinson's disease (PD) in two large prospective cohorts: the Nurses' Health Study (NHS) and Health Professionals' Follow‐Up Study (HPFS). Cox proportional hazards models were used

Smokeless tobacco use and the risk of Pa

Smokeless tobacco use and the risk of Parkinson's disease mortality

✍ Eilis J. O'Reilly; Marji L. McCullough; Ann Chao; S. Jane Henley; Eugenia E. Cal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

## Abstract We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 never‐smoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age‐adjusted ri

Reproductive factors, exogenous estrogen

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

✍ Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract To determine if reproductive factors or exogenous estrogen are associated with risk of Parkinson's disease (PD), we conducted a prospective study with 22 years of follow‐up among postmenopausal participants in the Nurses' Health Study. Relative risks (RRs) and 95% confidence intervals (

Lower risk of Parkinson's disease in an

Lower risk of Parkinson's disease in an admixed population of European and Indian origins

✍ Mona Ragothaman; Uday A. Murgod; Gopalkrishna Gururaj; Subbakrishna D. Kumaraswa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

## Abstract We studied whether the occurrence of Parkinson's disease (PD) in the Anglo‐Indians, an admixed population of European and Asian Indian origin, differs from Indians living in the same environment. Epidemiological studies show considerably higher prevalence of PD amongst white compared to